Taltz (Ixekizumab) has shown positive results for many people with moderate to severe plaque psoriasis or psoriatic arthritis. It works by targeting interleukin-17A, a protein that promotes inflammation. Some individuals report significant improvement in their symptoms, but results can vary. Common side effects include Show Full Answer

Taltz (Ixekizumab) has shown positive results for many people with moderate to severe plaque psoriasis or psoriatic arthritis. It works by targeting interleukin-17A, a protein that promotes inflammation. Some individuals report significant improvement in their symptoms, but results can vary. Common side effects include injection site reactions and upper respiratory infections. For more details, visit: [Taltz](https://www.mypsoriasisteam.com/treatments/taltz).

 This AI-generated response comes from MyPsoriasisTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Taltz (Ixekizumab) for Psoriasis | MyPsoriasisTeam

FDA Approves New Oral Drug Sotyktu for Adults With Plaque Psoriasis | MyPsoriasisTeam